الحملات
View Allالوثائق
View Allالمركز الإعلامي
View All
SFDA and Saudi NIH Launch Five Initiatives to Advance Clinical Trials and Accelerate Innovative Medicines Development in Saudi Arabia
H.E. Dr. Hisham S. Aljadhey, CEO of the Saudi Food and Drug Authority (SFDA), launched a number of strategic initiatives in clinical trials in...
SFDA Grants Breakthrough Designation to "Wilsirdli" for Early, Advanced, and Metastatic ER+/HER2- Breast Cancer
The Saudi Food and Drug Authority (SFDA) has approved a request by Roche Pharmaceuticals to designate "Wilsirdli" under its Breakthrough Medicine...
SFDA CEO: Crown Prince’s Blood Donation Initiative Embodies Noble Values and Helps Save Lives
H.E. the CEO of the Saudi Food and Drug Authority (SFDA), Dr. Hisham S. Aljadhey, expressed his gratitude and appreciation to HRH Prince Mohammed bin...
SFDA Approves Registration of "Jascayd" for the Treatment of Idiopathic Pulmonary Fibrosis
The Saudi Food and Drug Authority (SFDA) has approved the registration of Jascayd (nerandomilast) for the treatment of adult patients with idiopathic...
SFDA Grants Breakthrough Designation to "Infilbray" for the Treatment of Patients with Type 3 Gaucher Disease
The Saudi Food and Drug Authority (SFDA) has granted Breakthrough Designation to Infilbray (venglustat), developed by Sanofi, for the treatment of...
SFDA CEO: Royal Address Reaffirms the Kingdom’s Pivotal Role in Advancing Peace and Sustaining Development
H.E. Dr. Hisham S. Aljadhey, CEO of the Saudi Food and Drug Authority (SFDA), commended the contents of the Royal Address delivered by HRH Prince...
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.